New CPT Codes Describe Emerging Technologies in the Treatment of Heart Failure
Bowman, S.
Journal of Ahima 88(4): 44-47
2017
ISSN/ISBN: 1060-5487 PMID: 29412571 Document Number: 693657
Document emailed within 1 workday
Related Documents
Beebe, M. 2003: CPT category III codes cover new, emerging technologies. New codes developed to address issues in light of HIPAA Journal of Ahima 74(9): 82Tunuguntla, A. 2007: Emerging drug therapies for the management of acute decompensated heart failure Tennessee Medicine: Journal of the Tennessee Medical Association 100(11): 33-37
Landström, N.; Kesek, M.; Jensen, S.M. 2013: Too few patients get heart failure pacemakers. it can provide better treatment in heart failure and left bundle branch block Lakartidningen 110(5): 216-219
Gomberg-Maitland, M.; Baran, D.A.; Fuster, V. 2001: Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist Archives of Internal Medicine 161(3): 342-352
Gunn, L.; Smith, M.T. 2004: Emerging biomarker technologies Iarc Scientific Publications 2004(157): 437-450
O'Connell, J.B.; Cobb, A.B. 1996: Heart failure evaluation and treatment in Mississippi: results from a survey of the Mississippi Foundation for Medical Care. Heart Failure Study Group Journal of the Mississippi State Medical Association 37(7): 648-652
Smith, A.P.; Hall, P.A.; Marcello, D.M. 2004: Emerging technologies in breast cancer detection Radiology Management 26(4): 16-24; Quiz: 25-27
Iarustovskiĭ, M.B.; Nazarova, E.I. 2006: Hybrid technologies of renal replacement therapy in the treatment of multiple organ failure in cardiosurgical patients Anesteziologiia i Reanimatologiia 3: 67-70
Cohen, B.L. 1990: Emerging technologies in the field of healthcare: enhancing the interface to the medical professional Annals of the Academy of Medicine Singapore 19(5): 627-639
Widimsky, J. 1975: Heart failure. Pathogenesis of heart failure and diagnosis of the incipient stage of heart failure Cor et Vasa 17(4): 302-314
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Jongbloed, K.; Parmar, S.; van der Kop, M.; Spittal, P.M.; Lester, R.T. 2015: Recent Evidence for Emerging Digital Technologies to Support Global HIV Engagement in Care Current Hiv/Aids Reports 12(4): 451-461
Nissen, S.E. 2002: Emerging technologies in coronary artery disease assessment: insights provided by intravascular ultrasound Managed Care 11(10 Suppl): 8-14
Emerich, D.F. 2004: The emerging technologies of neural xenografting and stem cell transplantation for treating neurodegenerative disorders Drugs of Today 40(3): 271
Wilson, E.J.; Stephens, J.C.; Rai Peterson, T.; Fischlein, M. 2009: Carbon capture and storage in context: the importance of state policy and discourse in deploying emerging energy technologies Energy Procedia 1(1): 4519-4526
Fedorova, T.A.; Il'ina, I.V.; Sotnikova, T.I.; Rybakova, M.K. 2004: Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease Klinicheskaia Meditsina 82(11): 15-20
Cherkavskaia, O.V.; Rudenko, B.A.; Kochetov, A.G.; Savchenko, A.P.; Gerasimov, A.M. 2012: Clinical results of the use of new bioengineering technologies (endothelial precursor cell-capturing stents) in the treatment of coronary heart disease Vestnik Rentgenologii i Radiologii 1: 9-16
Kuriata, A.V.; Karavanskaia, I.L.; Kushnir, I.S. 2011: The use of metabolic therapy in the treatment of ischemic heart disease in hemodynamically formed insignificant aortic stenosis with chronic heart failure Likars'ka Sprava 2011(7-8): 51-58
Takahashi, H. 2007: Pathophysiology of heart failure and the biomarkers; brain natriuretic hormone as the class-1 recommendation by the new Japanese Guideline for Heart Failure Rinsho Byori. Japanese Journal of Clinical Pathology 55(12): 1088-1096
Feenstra, J.; Heerdink, E.R.; Grobbee, D.E.; Stricker, B.H.Ch. 2002: Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study Archives of Internal Medicine 162(3): 265-270